Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease
- 27 February 2023
- journal article
- review article
- Published by Springer Nature in Cellular and Molecular Neurobiology
- Vol. 43 (6) , 2491-2523
Abstract
The development of early non-invasive diagnosis methods and identification of novel biomarkers are necessary for managing Alzheimer’s disease (AD) and facilitating effective prognosis and treatment. AD has multi-factorial nature and involves complex molecular mechanism, which causes neuronal degeneration. The primary challenges in early AD detection include patient heterogeneity and lack of precise diagnosis at the preclinical stage. Several cerebrospinal fluid (CSF) and blood biomarkers have been proposed to show excellent diagnosis ability by identifying tau pathology and cerebral amyloid beta (Aβ) for AD. Intense research endeavors are being made to develop ultrasensitive detection techniques and find potent biomarkers for early AD diagnosis. To mitigate AD worldwide, understanding various CSF biomarkers, blood biomarkers, and techniques that can be used for early diagnosis is imperative. This review attempts to provide information regarding AD pathophysiology, genetic and non-genetic factors associated with AD, several potential blood and CSF biomarkers, like neurofilament light, neurogranin, Aβ, and tau, along with biomarkers under development for AD detection. Besides, numerous techniques, such as neuroimaging, spectroscopic techniques, biosensors, and neuroproteomics, which are being explored to aid early AD detection, have been discussed. The insights thus gained would help in finding potential biomarkers and suitable techniques for the accurate diagnosis of early AD before cognitive dysfunction. Graphical AbstractKeywords
This publication has 254 references indexed in Scilit:
- Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s diseaseTranslational Psychiatry, 2013
- Soluble amyloid precursor protein β as blood-based biomarker of Alzheimer’s diseaseTranslational Psychiatry, 2013
- Magnetocardiography with a modular spin-exchange relaxation-free atomic magnetometer arrayPhysics in Medicine & Biology, 2012
- Protein Phosphatase 2A Interacts with the Na+,K+-ATPase and Modulates Its Trafficking by Inhibition of Its Association with ArrestinPLOS ONE, 2011
- Genome-wide Analysis of Genetic Loci Associated With Alzheimer DiseaseJAMA, 2010
- The clinical use of structural MRI in Alzheimer diseaseNature Reviews Neurology, 2010
- Automated segmentation of hippocampal subfields from ultra‐high resolution in vivo MRIHippocampus, 2009
- Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2008
- Biomarkers for Early Detection of Alzheimer PathologyNeurosignals, 2007
- Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cellsNature Cell Biology, 2007